Her Option is an FDA approved treatment for women suffering from excessive menstrual bleeding who wish to avoid a hysterectomy. The product line had revenue of approximately $10m over the last year. Cooper expects the acquisition to be neutral to its fiscal 2010 consolidated earnings excluding transaction costs.

Robert Weiss, president and chief executive officer of Cooper, said: “The Her Option product line is very well-regarded and fits perfectly with CooperSurgical’s strength of bringing premier products to the OB/GYN office space.”

Minnetonka, Minnesota-based American Medical Systems is a supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women.

California-based Cooper Companies manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units.

CooperVision develops, manufactures and markets a broad range of contact lenses for the worldwide vision correction market.

CooperSurgical develops, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories used primarily by gynecologists and obstetricians.